GenSight Biologics S.A. (EPA:SIGHT)
France
· Delayed Price · Currency is EUR 0.1944
+0.0024 (1.25%)
May 30, 2025, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €24.97 million as of May 30, 2025. Its market cap has decreased by -37.57% in one year.
Market Cap
24.97M
Enterprise Value
41.62M
Revenue
2.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 24.97M, a decrease of -90.10%. That is a compound annual growth rate of -22.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 115.64B |
| Sanofi | 113.05B |
| Sartorius Stedim Biotech | 18.89B |
| bioMérieux | 13.87B |
| Eurofins Scientific SE | 10.20B |
| Ipsen | 8.51B |
| Virbac | 2.71B |
| emeis Société anonyme | 1.68B |